159 related articles for article (PubMed ID: 33896386)
1. Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer.
Xu J; Li N; Deng W; Luo S
Bioengineered; 2021 Dec; 12(1):1286-1298. PubMed ID: 33896386
[TBL] [Abstract][Full Text] [Related]
2. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
Abou-Zeid AA; Azzam AZ; Kamel NA
Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
5. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
6. Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Ben-Dayan MM; Ow TJ; Belbin TJ; Wetzler J; Smith RV; Childs G; Diergaarde B; Hayes DN; Grandis JR; Prystowsky MB; Schlecht NF
Cancer Med; 2017 Feb; 6(2):397-407. PubMed ID: 28102032
[TBL] [Abstract][Full Text] [Related]
7. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
8. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH
APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships among chromosome aneuploidy, promoter hypermethylation, and protein expression of the CDKN2A gene in individuals from northern Brazil with gastric adenocarcinoma.
Guimarães AC; Lima EM; Khayat AS; Girão Faria MH; Barem Rabenhorst SH; Pitombeira MV; Assumpção PP; de Oliveira Bahia M; Lima de Lima PD; de Arruda Cardoso Smith M; Burbano RR
Cancer Genet Cytogenet; 2007 Nov; 179(1):45-51. PubMed ID: 17981214
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
12. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
Mohseny AB; Tieken C; van der Velden PA; Szuhai K; de Andrea C; Hogendoorn PC; Cleton-Jansen AM
Genes Chromosomes Cancer; 2010 Dec; 49(12):1095-103. PubMed ID: 20737480
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
Zhang D; Wang T; Zhou Y; Zhang X
Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex.
Alves MK; Faria MH; Neves Filho EH; Ferrasi AC; Pardini MI; de Moraes Filho MO; Rabenhorst SH
Int J Surg; 2013; 11(7):549-53. PubMed ID: 23721661
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.
Iolascon A; Giordani L; Moretti A; Tonini GP; Lo Cunsolo C; Mastropietro S; Borriello A; Ragione FD
Pediatr Res; 1998 Jan; 43(1):139-44. PubMed ID: 9432125
[TBL] [Abstract][Full Text] [Related]
18. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
19. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
